M&A - Oklo Inc.

Form Type: 10-Q

Filing Date: 2025-05-13

Corporate Action: Acquisition

Type: New

Accession Number: 000162828025025166

Filing Summary: Oklo Inc. reports a significant business development that involved the acquisition of Atomic Alchemy, Inc. on February 28, 2025. This acquisition was executed through a statutory merger, aiming to integrate Oklo's nuclear technology with Atomic Alchemy’s expertise in radioisotopes to capitalize on growing opportunities in medical, energy, industry, defense, and artificial intelligence sectors. The filing includes unaudited financial results for the three months ended March 31, 2025, highlighting a net loss of $9,810,000 compared to a net loss of $24,022,000 for the same period in 2024. The consolidated balance sheet reflects total assets of $302,146,000 and total liabilities of $32,816,000 as of March 31, 2025. The document reinforces Oklo Inc.'s positioning in the nuclear energy sector and outlines financial performance and operational milestones since the company's recapitalization in May 2024.